The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

Disclosure: Dr Boreham is not a qualified medical practitioner and does not possess a doctorate of any sort. The last time he ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

BMS says it is combining AI and machine learning with its researchers’ expertise in drug targets and mechanisms of action, to ...

Drug development is ... notable action can come from within patient organisations to drive change and help create new treatments. She explained that, after a number of clinical trials were ...

The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...

Preferred pharmacy networks present a controversy that pits two essential providers – pharmacies and drug insurers – against ...

German drugmaker Grünenthal pushed its latest opioid as a safer option. People around the world got hooked. Madlen Davies, Hristio Boytchev, and Rafael Cabrera report.

Lumping cannabis in with drugs considered to have no medical value undermines patient access in Maine and beyond.

Healthcare experts advocate genetic counselling, family tree mapping, and incentives for indigenous drug production to address rare diseases.

One diet came out a clear winner in a 30-year study involving more than 105,000 men and women and eight diets, researchers ...

The rescheduling of marijuana may remove regulatory hurdles and expand the breadth of research beyond pain management.